Triaziquone

Triaziquone

SCHEMBL9644546

C[Si](C)(C)n1c(N)nc2[nH]cnc2c1=O.O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10597939 0.81 PNP (0.33)
Triaziquone SCHEMBL149876 0.69 MAPT (0.46)
Triaziquone SCHEMBL2208738 0.67 MAPT (0.46)
Triaziquone SCHEMBL588726 0.67 MAPT (0.46)
Triaziquone SCHEMBL7117809 0.67 MAPT (0.44)
Triaziquone SCHEMBL8303 0.67 DNMT1 (0.48)
Triaziquone SCHEMBL8829051 0.67 MAPT (0.42)
SCHEMBL2385669 0.66 PNP (0.34)
Triaziquone SCHEMBL10906735 0.66 HTT (0.43)
Triaziquone SCHEMBL11039269 0.66 MAPT (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0130126-B1 (S)-9-(2,3-DIHYDROXY-1-PROPOXYMETHYL) GUANINE AND ITS ACYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTIHERPETIC AGENTS MERCK & CO. INC. (US) 1987-08-26 EP claimed
EP-0272446-B1 NOVEL ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1992-11-11 EP disclosed
US-4360522-A VIRICIDES BURROUGHS WELLCOME CO. (US) 1982-11-23 US disclosed
US-4294831-A ANTIVIRAL ACTIVITY BURROUGHS WELLCOME CO. (US) 1981-10-13 US disclosed
US-4287188-A PARTICULARLY 9-(2-HYDROXYETHOXYMETHYL) GUANINE MONOPHOSPHATE AND SALTS, USEFUL AS ANTIVIRIAL AGENTS BURROUGHS WELLCOME CO. (US) 1981-09-01 US disclosed
US-4146715-A ANTIVIRAL AGENTS BURROUGHS WELLCOME CO. (US) 1979-03-27 US disclosed